Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Open Access
- 29 November 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 450 (7170), 741-744
- https://doi.org/10.1038/nature05998
Abstract
Crystal structures of complexes between the epidermal growth factor receptor (EGFR) kinase domain and a fragment of its feedback inhibitor MIG6 reveal an allosteric inhibition mechanism. MIG6 binds the cyclin/CDK-like asymmetric dimer interface of EGFR and blocks formation of the activating dimer. Members of the epidermal growth factor receptor family (EGFR/ERBB1, ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are key targets for inhibition in cancer therapy1. Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the carboxy-terminal lobe (C lobe) of one kinase domain induces an active conformation in the other2. The cytoplasmic protein MIG6 (mitogen-induced gene 6; also known as ERRFI1) interacts with and inhibits the kinase domains of EGFR and ERBB2 (refs 3–5). Crystal structures of complexes between the EGFR kinase domain and a fragment of MIG6 show that a ∼25-residue epitope (segment 1) from MIG6 binds to the distal surface of the C lobe of the kinase domain. Biochemical and cell-based analyses confirm that this interaction contributes to EGFR inhibition by blocking the formation of the activating dimer interface. A longer MIG6 peptide that is extended C terminal to segment 1 has increased potency as an inhibitor of the activated EGFR kinase domain, while retaining a critical dependence on segment 1. We show that signalling by EGFR molecules that contain constitutively active kinase domains still requires formation of the asymmetric dimer, underscoring the importance of dimer interface blockage in MIG6-mediated inhibition.This publication has 22 references indexed in Scilit:
- The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activityOncogene, 2007
- Activated Cdc42-associated Kinase 1 Is a Component of EGF Receptor Signaling Complex and Regulates EGF Receptor DegradationMolecular Biology of the Cell, 2007
- Evidence that MIG-6 is a tumor-suppressor geneOncogene, 2006
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Structural Basis for Inhibition of the Insulin Receptor by the Adaptor Protein Grb14Molecular Cell, 2005
- The Active Conformation of the PAK1 Kinase DomainStructure, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- EGF signalling amplification induced by dynamic clustering of EGFRBiochemical and Biophysical Research Communications, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagationNature, 2003